Clinical trial • Phase I • Oncology
GEN1106 for Metastatic solid tumors | Advanced malignant solid tumors
Phase I trial of GEN1106 for Metastatic solid tumors | Advanced malignant solid tumors. 53 participants.
Overview
- Trial Therapeutic Area
- Oncology
- Trial Disease
- Metastatic solid tumors | Advanced malignant solid tumors
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 09-01-2026
- First CTIS Authorization Date
- 27-04-2026
Trial design
Phase I trial across 5 sites in Spain.
- Target Sample Size
- 53
Eligibility
Recruits 53 Vulnerable population selected; no details on consent or assent processes provided in the available record..
- Vulnerable Population
- Vulnerable population selected; no details on consent or assent processes provided in the available record.
Recruitment
- Planned Sample Size
- 53
- Recruitment Window Months
- 30
Geography
- Total Number Of Sites
- 5
- Total Number Of Participants
- 53
Spain
- Earliest CTIS Part Ii Submission Date
- 24-03-2026
- Latest Decision Or Authorization Date
- 27-04-2026
- Processing Time Days
- 34
- Number Of Sites
- 5
- Number Of Participants
- 50
Sites
- Site Name
- Hospital Universitario Quironsalud Madrid
- Department Name
- NEXT Oncology
- Contact Person Name
- Valentina Boni
- Contact Person Email
- vboni@nextoncology.eu
- Site Name
- Hospital Hm Nou Delfos
- Department Name
- START
- Contact Person Name
- Tatiana Hernandez Guerrero
- Contact Person Email
- tatiana.hernandez@start-barcelona.com
- Site Name
- Hospital Universitario Fundacion Jimenez Diaz
- Department Name
- START
- Contact Person Name
- Ester Garcia Lorenzo
- Contact Person Email
- ester.garcia@startmadrid.com
- Site Name
- Hospital Universitari Vall D Hebron
- Department Name
- Oncology - Phase I
- Contact Person Name
- Elena Garralda Cabanas
- Contact Person Email
- egarralda@vhio.net
- Site Name
- Hospital Universitario Hm Sanchinarro
- Department Name
- START
- Contact Person Name
- Juan Francisco Rodriguez Moreno
- Contact Person Email
- juanfran.rodriguez@startmadrid.com
Sponsor
Primary sponsor
- Full Name
- Genmab A/S
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- Denmark
Investigational products
- Investigational Product Name
- GEN1106
Related trials
Other published trials that may interest you.
- GDC-9545 for Locally advanced or metastatic estrogen receptor-positive breast cancer
- Abemaciclib for Stage IV lung cancer | Breast cancer
- BGB-43395 for Advanced or metastatic solid tumors | Hormone receptor positive HER2 negative breast cancer
- AZD9833 for Estrogen receptor-positive HER2-negative advanced breast cancer
- Pembrolizumab for Classical Hodgkin lymphoma | Melanoma | Solid tumours (MSI-H/dMMR) | Solid tumours (TMB-H)